Search results for "Hemolysis"

showing 9 items of 89 documents

Cytoprotective effects of the antioxidant phytochemical indicaxanthin in beta-thalassemia red blood cells

2006

Antioxidant phytochemicals are investigated as novel treatments for supportive therapy in beta-thalassemia. The dietary indicaxanthin was assessed for its protective effects on human beta-thalassemic RBCs submitted in vitro to oxidative haemolysis by cumene hydroperoxide. Indicaxanthin at 1.0-10 microM enhanced the resistance to haemolysis dose-dependently. In addition, it prevented lipid and haemoglobin (Hb) oxidation, and retarded vitamin E and GSH depletion. After ex vivo spiking of blood from thalassemia patients with indicaxanthin, the phytochemical was recovered in the soluble cell compartment of the RBCs. A spectrophotometric study showed that indicaxanthin can reduce perferryl-Hb ge…

congenital hereditary and neonatal diseases and abnormalitiesAntioxidantErythrocytesPyridinesmedicine.medical_treatmentindicaxanthinphytochemicalBiochemistryHemolysisAntioxidantschemistry.chemical_compoundHemoglobinsAntioxidants betalainhemic and lymphatic diseasesSettore BIO/10 - BiochimicamedicineBenzene DerivativesHumansVitamin ETraditional medicineDose-Response Relationship DrugChemistrybeta-ThalassemiaBeta thalassemiaGeneral Medicinemedicine.diseaseLipid MetabolismGlutathionehaemoglobinBetaxanthinsPhytochemicalBiochemistryCytoprotectionSpectrophotometryCase-Control StudiesHeminAntioxidants betalains haemoglobin indicaxanthin phytochemicals red blood cellsIndicaxanthinOxidation-Reductionred blood cells
researchProduct

Dependence of T-lymphocyte activation on the extent of cellular damage

2010

Mechanically damaged cells release intracellular substances, resulting in the activation of CD4- and CD8-positive T-lymphocytes. The goal of this investigation was to quantify and compare fractions of activated CD4- and CD8-positive T-lymphocytes, based on the quantity of damaged cells in a given blood sample. Blood samples were mechanically stressed by vortexing intensely. Subsequently, different quantities of distressed blood samples were mixed with samples of fresh, whole blood. Afterwards, the extent of CD4- and CD8-positive T-cell activation was examined in the mixture by flow cytometry. Sine-like curves of T-cell activation were observed for both CD4- (T-helper mediated) and CD8- (cyt…

medicine.diagnostic_testT lymphocyteBiologymedicine.diseaseHemolysisFlow cytometryImmunologymedicineBiophysicsCytotoxic T cellCell damageIntracellularCD8Whole bloodInternational Journal of Immunological Studies
researchProduct

New hydrogel matrices containing an anti-inflammatory agent. Evaluation of in vitro release and photoprotective activity.

2002

In the present work. the preparation and characterization of hydrogels based on alpha,beta-polyaspartylhydrazide (PAHy) chemically crosslinked with ethyleneglycol diglycidylether (EGDGE) containing Tolmetin sodium salt, are reported. In particular, these samples have been prepared both as water swellable microparticles and as gels at two different crosslinking degrees. The incorporation of Tolmetin sodium salt in PAHy-EGDGE microparticles has been performed after the crosslinking reaction by a soaking procedure or during the formation of the network. The influence of drug loading procedure on Tolmetin release has been evaluated by performing in vitro release study in simulated gastrointesti…

medicine.drug_classPhotochemistrySodiumBiophysicsSynthetic membranechemistry.chemical_elementSalt (chemistry)BioengineeringIn Vitro TechniquesCrystallography X-RayAnti-inflammatoryHydrogel Polyethylene Glycol DimethacrylateBiomaterialsmedicineOrganic chemistryTolmetinchemistry.chemical_classificationChromatographyAnti-Inflammatory Agents Non-Steroidalmedicine.diseaseIn vitroHemolysischemistryMechanics of MaterialsSelf-healing hydrogelsCeramics and CompositesTolmetinmedicine.drugBiomaterials
researchProduct

In-vitro assessment of centrifugal pumps for ventricular assist.

1990

Currently two major types of centrifugal pumps are commercially available for ventricular assist: the Biomedicus-cone (Group I) and the Centrimed-impeller pump (now Sarns 3M) (Group II). To compare them for blood trauma and hemolysis, an in-vitro experiment was designed with a Stockert roller pump as a standard control (Group III). The in-vitro circuit was constructed consisting of a pump head, electromagnetic flow probe, polyvinyl chloride tubing and a reservoir, identical for all groups. Human ACD blood was used for priming and was circulated with a flow rate of 2 L/min for 24 h. Blood samples were taken at 0, 1, 3, 6, 12, and 24 h and zero control values were subtracted from the resultin…

medicine.medical_specialtyGroup iiBiomedical EngineeringMedicine (miscellaneous)Peristaltic pumpBioengineeringIn Vitro TechniquesHemolysisBiomaterialschemistry.chemical_compoundInternal medicineLactate dehydrogenasemedicineHumansHeart-Assist DevicesPump headHemolytic IndexGeneral MedicineEquipment Designmedicine.diseaseCentrifugal pumpHemolysisBloodchemistryCardiologyHeart-Assist DevicesBlood Flow VelocityBiomedical engineeringArtificial organs
researchProduct

Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome.

2004

Background & Aims: The HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome is a life-threatening complication during pregnancy. The associated liver disease may be severe, and maternal hepatic complications may progress to the point that transplantation becomes necessary. CD95 (APO-1, Fas)-mediated apoptosis of liver cells is one of the major pathogenic mechanisms during liver disease. The interaction of CD95 with its ligand, CD95L(FasL), induces apoptosis and thus the source of the death-inducing ligand is critical for understanding the pathomechanism of liver damage involving the CD95-system. Methods: Sera from HELLP patients were analyzed and used in cell culture experiment…

medicine.medical_specialtyHELLP SyndromeFas Ligand ProteinHELLP syndromePlacentaApoptosisBiologyHepatic ComplicationFas ligandAcute fatty liver of pregnancyLiver diseaseJurkat CellsMicePregnancyInternal medicinemedicineAnimalsHumansCells CulturedTransaminasesMembrane GlycoproteinsHepatologymedicine.diagnostic_testLiver cellGastroenterologymedicine.diseaseHemolysisMolecular WeightEndocrinologyLiverCancer researchHepatocytesFemaleLiver function testsGastroenterology
researchProduct

D-penicillamine in Wilson's disease presenting as acute liver failure with hemolysis.

1982

Wilson's disease in a young woman presenting with an acute course is described. The clinical manifestations were fulminant hepatic failure associated with marked intravascular hemolysis. Immediate D-penicillamine and high-dose steroid therapy did not influence the course of the disease. Necropsy revealed an increased hepatic copper content and cirrhosis with extensive necrosis of the liver.

medicine.medical_specialtyPathologyCirrhosisAdolescentPhysiologyDiseaseGastroenterologyHemolysisFulminant hepatic failureHepatolenticular DegenerationInternal medicinemedicineHumansGlucocorticoidsbusiness.industryLiver DiseasesPenicillaminePenicillamineGastroenterologyLiver failureCeruloplasminHepatologyMiddle Agedmedicine.diseaseHemolysisWilson's diseaseAcute DiseaseFemalebusinessCoppermedicine.drugDigestive diseases and sciences
researchProduct

Epidemiological, biological and clinical update on exercise-induced hemolysis

2019

Exercise-induced hemolysis can be conventionally defined as rupture and destruction of erythrocytes during physical exercise. The currently available epidemiologic information attests that a substantial degree of exercise-induced hemolysis is commonplace after short-, medium-, long- and ultra-long distance running, as reflected by significant decrease of serum or plasma haptoglobin and significant increase of plasma concentration (or overall blood content) of free hemoglobin. This paraphysiological intravascular hemolysis is typically mild (average variations of hemolysis biomarkers are usually comprised between 1.2- and 1.8-fold), almost self-limiting (completely resolving within 24-48 hou…

medicine.medical_specialtyPopulationPhysical exerciseReview Article030204 cardiovascular system & hematologyExercise-induced hemolysisHemolysis03 medical and health sciences0302 clinical medicinephysical exerciseEndurance trainingInternal medicinemedicineHemolysis; hemoglobin; red blood cells (RBC); sports physical exerciseeducationeducation.field_of_studyred blood cells (RBC)biologybusiness.industryHaptoglobinErythrocyte fragility030229 sport sciencesGeneral Medicinehemoglobinmedicine.diseaseHemolysisHypotonic ShockEndocrinologybiology.proteinsportsbusinessAnnals of Translational Medicine
researchProduct

On the hemagglutinating and hemolytic activity of measles virus variants.

1967

The hemagglutinating (HA) and hemolytic (HL) activity of two measles virus variants, differing with regard to type of CPE and other characteristics, have been investigated.

medicine.medical_specialtybiologyvirusesHemagglutinationGenetic VariationGeneral Medicinebiochemical phenomena metabolism and nutritionbiology.organism_classificationVirologyHemolysisMeasles virusMedical microbiologyCytopathogenic Effect ViralCell cultureInfectious disease (medical specialty)Giant cellMeasles virusVirologymedicineHeLa CellsArchiv fur die gesamte Virusforschung
researchProduct

Protective effects of plasma replacement fluids on erythrocytes exposed to mechanical stress

2000

Haemoglobin release from 40 suspensions of packed red blood cells in modified fluid gelatin, 4% albumin solution, 6% hydroxyethyl starch and normal saline was investigated in vitro during circulation with a roller pump from a heart-lung machine for 120 min at a flow rate of 2.5 l.min-1 at room temperature. The lowest haemoglobin release was obtained with erythrocytes in modified fluid gelatin, whereas free haemoglobin concentrations became progressively higher with albumin, hydroxyethyl starch and normal saline [median free haemoglobin (interquartile range) after 120 min circulation: gelatin 493 (360-601) mg.l-1, albumin 692 (590-1111) mg.l-1, hydroxyethyl starch 1121 (692-1518) mg.l-1, nor…

medicine.medical_specialtyfood.ingredientChromatographybusiness.industrymedicine.medical_treatmentExtracorporeal circulationAlbuminHydroxyethyl starchmedicine.diseaseHaemolysisGelatinHemolysisSurgeryRed blood cellAnesthesiology and Pain Medicinefoodmedicine.anatomical_structureMedicinebusinessSalinemedicine.drugAnaesthesia
researchProduct